Innovating Works

H2020

Cerrada
HORIZON-JU-IHI-2022-03-03
HORIZON-JU-IHI-2022-03-03: Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency
ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes:
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 15-03-2023.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes:

Patients will be offered improved, evidence-based, innovative hospital treatment combinations that lead to better outcomes.Healthcare professionals will have access to improved clinical decision support systems that will recommend personalised treatments using patient-specific datasets collected in the hospital setting.Healthcare systems will have better evidence on cost-effective combinations of interventions and how these combinations can increase hospital efficiency.Researchers will have improved information on treatment combinations to facilitate the development of improved interventions.
Scope:Patients admitted to hospital to undergo elective or non-elective procedures typically require recovery and rehabilitation to get back to normal life. New treatment approaches such as minimally invasive surgical approaches, locoregional interventions, novel imaging and diagnostic techniques, clinical decision support systems, and robotics have the potential to reduce complicat... ver más

ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes:

Patients will be offered improved, evidence-based, innovative hospital treatment combinations that lead to better outcomes.Healthcare professionals will have access to improved clinical decision support systems that will recommend personalised treatments using patient-specific datasets collected in the hospital setting.Healthcare systems will have better evidence on cost-effective combinations of interventions and how these combinations can increase hospital efficiency.Researchers will have improved information on treatment combinations to facilitate the development of improved interventions.
Scope:Patients admitted to hospital to undergo elective or non-elective procedures typically require recovery and rehabilitation to get back to normal life. New treatment approaches such as minimally invasive surgical approaches, locoregional interventions, novel imaging and diagnostic techniques, clinical decision support systems, and robotics have the potential to reduce complications, facilitate faster recovery, and help increase hospital efficiencies. However, due to limitations in interoperability, reliable evidence and suitable guidelines, these innovative approaches, treatment options and clinical decision support systems are not being optimally combined to provide the best patient care.

Projects funded under this topic should address this challenge by showcasing how existing hospital interventions, treatment approaches and technologies can be optimally combined to improve patient outcomes, enhance patient pathways, generate efficiency gains, reduce hospital staffing challenges, help to lower costs, and decrease societal burden.

In particular, projects should:

Access and integrate clinical data routinely generated using existing technologies during the patient journey (e.g. medical history profile of patients, diagnosis achieved, for example, by medical imaging and in-vitro diagnostic (IVD) tests, digital information generated during the hospital procedure, vital signs and anaesthesia management, electronic healthcare record systems (EHRs), and drug prescriptions such as analgesics). The interoperability of these data should be addressed as appropriate. Suitable, secure IT infrastructure to support edge and cloud computing in compliance with the general data protection regulation (GDPR) and other data privacy policies at national and local levels should be utilised.Train and clinically validate explainable AI algorithms to support the development of training programmes, procedure planning and intraoperative assistance solutions, including clinical decision support systems.Demonstrate, via use cases using these data & algorithms, how combinations of and/or synergies between the above-mentioned tools, technologies, and therapeutic approaches can be harnessed to improve patient care. This should include comparing the combination of innovative interventional approaches and clinical decision support systems (CDSS) versus limited or no systematic combination of these innovative interventional approaches and CDSS.Implement tools to confirm successful treatment during or after the procedure and monitor therapy response and disease regression.Develop and implement new methodologies to assess and demonstrate the added value of combining innovative interventional approaches and clinical decision support systems to all relevant stakeholders.Encourage the uptake of the results of the project through a strong communication and outreach plan, including the publication of a gap assessment in order to guide future research in this field. Applicants are expected to consider allocating appropriate resources to explore synergies with other relevant initiatives and projects including any projects resulting from Horizon Europe Cluster 1 Health topics, and, where relevant, seek engagement with regulators (e.g. through the EMA Innovation Task Force, scientific advice).


Expected Impact:The following impacts are expected:

Improve patient outcomes of hospital care and foster faster recovery by overcoming issues of fragmentation through combining innovative interventional approaches.Seamless and successful implementation in hospital settings of cross-sectoral innovations, integrated products and services delivering proven benefits to patients, healthcare systems (including hospital staffing), and society as a whole.Advanced analytics/artificial intelligence (AI) supporting health research and innovation, resulting in improved clinical decision support for increased efficacy of treatment.
ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes: ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes:
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Subcontracting costs.
Purchase costs.
Other cost categories.
Indirect costs.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 4:. Es el primer paso para determinar si los componentes individuales funcionarán juntos como un sistema en un entorno de laboratorio. Es un sistema de baja fidelidad para demostrar la funcionalidad básica y se definen las predicciones de rendimiento asociadas en relación con el entorno operativo final. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Para el presupuesto subvencionable la intensidad de la ayuda en formato fondo perdido podrá alcanzar como minimo un 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.